Key takeaway: Neogen Chemicals Limited's investor presentation detailed the company's unaudited financial results for the quarter ended June 30, 2026. The presentation highlighted a 37% increase in standalone revenue to INR 252.3 crore and a 34% rise in consolidated revenue to INR 250.3 crore compared to the same quarter last year. EBITDA grew by 39% to INR 48.2 crore on a standalone basis, while profit after tax (PAT) increased by 37% to INR 19.4 crore. Management noted strong performance despite challenges from a temporary plant shutdown and rising input costs. The presentation also discussed ongoing expansion initiatives, including the reconstruction of the Dahej plant and plans for a Qualified Institutional Placement to raise up to INR 600 crore. Management emphasized the company's strategic focus on battery materials and sustainability initiatives, positioning Neogen as a key player in the lithium-ion battery sector.

Key takeaway: Neogen Chemicals Limited held its Q4 FY26 earnings conference call on May 18, 2026, where management discussed the company's financial performance and strategic developments. Management reported a consolidated revenue of INR 247 crore for Q4 FY26, reflecting a 22% year-on-year growth, with EBITDA increasing by 21% to INR 44 crore. The EBITDA margin was maintained at 17.8%. Management highlighted the challenges in the global chemical industry, including pricing volatility and supply chain disruptions, but noted strong demand in key sectors such as pharma and specialty applications. The company is transitioning towards battery materials, with a capital infusion of INR 161 crore from promoters to support this shift. Management set a revenue goal of INR 875 to INR 950 crore for FY27 on a standalone basis, excluding battery-related revenues, which are projected to exceed INR 300 crore. The call concluded with management expressing confidence in the company's growth trajectory and ongoing strategic initiatives.

Key takeaway: Neogen Chemicals Limited's investor presentation detailed the audited financial results for the quarter and financial year ended March 31, 2026. The presentation highlighted a 22% year-over-year revenue growth for Q4 FY26, reaching INR 249 crore, and an 11% increase for FY26, totaling INR 862 crore. Management reported strong performance despite supply chain disruptions and elevated input costs, with EBITDA margins sustained at 17.8%. The company noted a significant increase in profit after tax (PAT) for Q4 FY26, which rose 373% to INR 11.4 crore. The presentation also discussed ongoing expansion initiatives, particularly in the battery materials segment, with a focus on the Neogen Ionics project. Management emphasized the strategic capital infusion of INR 161 crore from promoters to support growth and expansion plans. The document concluded with an overview of the company's commitment to sustainability and corporate governance.

Key takeaway: During the Q3 FY26 earnings conference call, management reported a 9% revenue growth, with gross profit increasing by 13% and a margin expansion of around 150 basis points. They noted that EBITDA and PAT were impacted by transient costs related to the ramp-up of Neogen Ionics, operational expenses from a fire incident, and higher finance costs from the Dahej plant reconstruction. Management highlighted the receipt of INR 83.48 crore in insurance claims and ongoing discussions for the final settlement. They announced a joint venture with Japan's Morita Investment Limited for electrolyte salt production, with plans for commercial production at the Pakhajan greenfield project. Management expressed confidence in achieving growth ambitions and maintaining a strong market position despite challenges. They also discussed the financial strategy, including a proposed preferential issue of equity shares to the promoter group to raise up to INR 150 crore.

Key takeaway: Neogen Chemicals Limited's investor presentation detailed the company's un-audited financial results for the quarter and nine months ended December 31, 2025. The presentation highlighted an 8% revenue growth for Q3 FY26 compared to Q3 FY25, driven by increased volumes in both organic and inorganic chemicals. However, profitability was impacted by post-fire operating costs and higher interest expenses related to plant reconstruction. Management reported that the company received INR 83.48 crore from insurance claims related to a fire incident, with ongoing construction of a replacement plant. The presentation also outlined expansion initiatives in battery chemicals, including a joint venture with Japan's Morita Investment Limited to produce lithium salts. Management emphasized a strategic pivot towards a future-ready portfolio, particularly in battery materials, and noted the importance of upcoming approvals from large-scale customers for lithium salts. The document concluded with a focus on sustainability and corporate governance initiatives.